You are on Trendlyne United States. Click here to go to India website or make United States as your default

11.24 -2.34 (-17.23%)

56.64% Fall from 52W High

1.0M XNAS Volume

XNAS 03 Apr, 2025 5:30 PM (EDT)

Not Eligible
-
Expensive Valuation
6.2 / 100
Technically Neutral
58.4 / 100

CervoMed Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

CervoMed Inc Stock Analysis

CervoMed Inc stock analysis with key metrics, changes, and trends.

CervoMed Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Net Profit$16.29 M650.08%negative

Annual Net Profit fell 650.08% in the last year to $16.29 M. Its sector's average net profit growth for the last fiscal year was -32.35%.

Price to Earning Ratio-6-negative

Price to Earning Ratio is -6, which is negative.

Stock Price$11.24-49.28%negative

Stock Price fell 49.28% and underperformed its sector by 54.67% in the past year.

Quarterly Net profit$6.71 M183.86%negative

Quarterly Net profit fell 183.86% YoY to $6.71 M. Its sector's average net profit growth YoY for the quarter was -47.37%.

Mutual Fund Holding16.24 %-0.55%negative

Mutual Fund Holding decreased by 0.55% in the last quarter to 16.24.

Promoter Share Holding5.39 %0%neutral

Promoter Share Holding stayed the same in the most recent quarter at 5.39%.

Institutional Holding17.07 %0%neutral

Institutional Holding remained the same in the last quarter at 17.07%.

VIEW LESS


Loading data..

CervoMed Inc - Company Profile

What does CervoMed Inc do?

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

CervoMed Inc Management structure

All Gross Remunerations are in USD
Mr. William R. Elder
General Counsel, Corporate Secretary, Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year
Dr. J. William Tanner, PhD
Chief Financial Officer
-
2024
Gross Remuneration
Year
Dr. John J. Alam, M.D.
Chief Executive Officer, President and Director
-
2024
Gross Remuneration
Year
Ms. Kelly Blackburn
Senior Vice President, Clinical Development
-
2024
Gross Remuneration
Year
Dr. Robert Joseph Cobuzzi, Jr,PhD
Chief Operating Officer and Director
-
2024
Gross Remuneration
Year

CervoMed Inc Board of directors

All Gross Remunerations are in USD
Dr. Joshua S. Boger,PhD
Chairman of the Board
-
2024
Gross Remuneration
Year
Dr. John J. Alam, M.D.
Chief Executive Officer, President and Director
-
2024
Gross Remuneration
Year
Ms. Jane H. Hollingsworth
Independent Director
-
2024
Gross Remuneration
Year
Dr. Sylvie Gregoire,Pharm.D.
Director
-
2024
Gross Remuneration
Year
Mr. Jeffrey V. Poulton
Independent Director
-
2024
Gross Remuneration
Year
Mr. Frank Zavrl
Independent Director
-
2024
Gross Remuneration
Year

CervoMed Inc FAQ

How is CervoMed Inc today?
CervoMed Inc today is trading in the red, and is down by -17.23% at 11.24.
CervoMed Inc is currently trading down -17.23% on an intraday basis. In the past week the stock rose 45.78%. stock has been up 380.34% in the past quarter and fell -49.28% in the past year. You can view this in the overview section.